Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multi-metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00354744
What this trial is testing

High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma

Who this might be right for
Sarcoma
Children's Oncology Group 109
Not applicableStudy completedNCT00281801
What this trial is testing

Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Case Comprehensive Cancer Center 168
Testing effectiveness (Phase 2)Study completedNCT00026234
What this trial is testing

Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumLiver Metastases+4 more
National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)UnknownNCT05105464
What this trial is testing

Investigate the Safety of SYHA1815 in Subjects With Unresectable Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced Unresectable Carcinoma
Shanghai Runshi Pharmaceutical Technology Co., Ltd 97
Testing effectiveness (Phase 2)Study completedNCT00256711
What this trial is testing

Phase II Iressa Versus Vinorelbine (INVITE)

Who this might be right for
Non-Small-Cell Lung Carcinoma
AstraZeneca 192
Not applicableLooking for participantsNCT04743102
What this trial is testing

Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer

Who this might be right for
Rectal CancerNeoadjuvant TherapyComplete Remission+1 more
Beijing Chao Yang Hospital 260
Large-scale testing (Phase 3)UnknownNCT00643877
What this trial is testing

Trial of Preoperative Hepatic and Regional Arterial Chemotherapy (PHRAC) to Prevent Postoperative Liver Metastasis of Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Fudan University 600
Early research (Phase 1)Ended earlyNCT04671849
What this trial is testing

An Open Label, Multi-center, Phase I Clinical Study to Evaluate the Safety, Effectiveness and Pharmacokinetic Characteristics of SIM1803-1A in Patients With Locally Advanced/Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion Mutations.

Who this might be right for
Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion
Jiangsu Simcere Pharmaceutical Co., Ltd. 24
Not applicableEnrolling By InvitationNCT06883084
What this trial is testing

Clinical Relevance of Pathologic Regression IN Lymph Node for Locally Advanced Rectal Cancer

Who this might be right for
Rectal CancerLymph Node Metastasis
Yanhong Deng 1,080
Large-scale testing (Phase 3)Study completedNCT00004255
What this trial is testing

Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Chimeric Therapies
Not applicableStudy completedNCT03170284
What this trial is testing

Observational Study to Evalute the Efficacy and Safety of Avastin (Bevacizumab) in Addition to Platinum-Based Chemotherapy for First-Line Treatment of Participants With Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 150
Early research (Phase 1)Ended earlyNCT04242147
What this trial is testing

Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of KD033 (SAR445710) in Subjects With Metastatic or Locally Advanced Solid Tumors

Who this might be right for
Solid Tumor
Kadmon, a Sanofi Company 45
Not applicableNo Longer AvailableNCT00655252
What this trial is testing

Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy

Who this might be right for
Metastatic Renal Cell Cancer
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00060138
What this trial is testing

Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases

Who this might be right for
Breast CancerHypercalcemia of MalignancyMetastatic Cancer+1 more
Chugai Pharmaceutical
Large-scale testing (Phase 3)Active Not RecruitingNCT03653507
What this trial is testing

Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).

Who this might be right for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more
Astellas Pharma Global Development, Inc.
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Testing effectiveness (Phase 2)Active Not RecruitingNCT03971409
What this trial is testing

Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer

Who this might be right for
Stage III Breast CancerStage IIIA Breast CancerStage IIIB Breast Cancer+6 more
Laura Huppert, MD, BA 145
Large-scale testing (Phase 3)Active Not RecruitingNCT04689828
What this trial is testing

177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Novartis Pharmaceuticals 469
Testing effectiveness (Phase 2)Looking for participantsNCT06801665
What this trial is testing

FMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colorectal Cancer With Liver Metastasis

Who this might be right for
Colorectal Cancer Liver Metastasis
Hua Jiang 30
Early research (Phase 1)Study completedNCT00854867
What this trial is testing

Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis.

Who this might be right for
Solid Tumour Neoplastic MeningitisBrain Metastases
Mundipharma Research Limited 18
Next Page
507